Fundz

CellsBin Closes Series A Financing of Undisclosed Amount Led by 108 BioCapital to Advance Its Rare-Cell Intelligence™ Platform.

PRIVATESep 22, 2026

Round Type

Series A

ConnecticutBiotechnologyHealth CareArtificial IntelligenceHealth Diagnostics

Investors

108 BioCapital

Description

CellsBin announced the closing of its Series A financing led by 108 BioCapital. The funding will accelerate commercialization, strategic partnerships, product development, and expansion of CellsBin’s clinical and technical capabilities. The company focuses on building a new observational layer for precision medicine. Its platform aims to help researchers and clinicians understand therapeutic cell behavior and disease evolution.

Quick answer

CellsBin raised an undisclosed amount in a Series A round, dated September 22, 2026. Investors: 108 BioCapital. CellsBin is based in Connecticut, United States.

How much did CellsBin raise?
CellsBin raised an undisclosed amount in a Series A round on September 22, 2026.
Who invested in CellsBin?
108 BioCapital is named as investors in this round.
What does CellsBin do?
CellsBin is pioneering Rare-Cell Biology™ to reveal the rare cells that shape human health.
Where is CellsBin based and how big is it?
CellsBin is based in Connecticut, United States. Fundz records about 10 employees.
Who are the decision-makers at CellsBin?
Fundz holds 1 contact at CellsBin, including the General Partner. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Health Diagnostics and Biotechnology around the same time

Companies in the same sectors as CellsBin that raised within 45 days of this round, from Fundz verified event records.

  • Laza Medical raised $160M (Series B) on November 4, 2026.
  • Pathos AI raised $237M (Series E) on October 23, 2026.
  • BioStack raised $9.5M (Seed) on October 22, 2026.
  • Coherence Neuro raised $45M (Series A) on October 22, 2026.
  • Wavena raised $150K (Seed) on October 8, 2026.
  • AIBORN Ltd raised an undisclosed amount on October 5, 2026.

Who to call at CellsBin, and when

A new round usually means CellsBin is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day CellsBin raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at CellsBin, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at CellsBin. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

CellsBin

Location

Connecticut, United States

About

CellsBin is pioneering Rare-Cell Biology™ to reveal the rare cells that shape human health. It's Rare-Cell Intelligence™ Platform integrates advanced microfluidics, multimodal imaging, single-cell analysis and artificial intelligence to detect, characterize and monitor rare cells at scale. Through applications in precision diagnostics, therapeutic-cell monitoring and translational research, CellsBin is working to enable smarter decisions, earlier care and better lives.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment CellsBin raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsShom, General Partner hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for CellsBin's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

CellsBin raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.